Latest Management of cancer Stories
Modified Citrus Pectin could help overcome prostate cancer radio-resistance PHILADELPHIA, April 22, 2015 /PRNewswire/ -- Scientists at Tel Aviv Medical Center, Israel, have
National cancer research nonproft raises money to fund cell and gene therapy research Stamford, CT (PRWEB) April 21, 2015 Alliance for Cancer Gene Therapy
GUILDFORD, England, April 20, 2015 /PRNewswire/ -- ANGLE plc (AIM:AGL OTCQX:ANPCY), the specialist medtech company, is pleased to announce that the Sidney Kimmel Cancer Center at Thomas Jefferson
Collaboration to provide expanded use of Paradigm Cancer Diagnostic (PCDx(TM)) service by oncologists across large oncology network SCOTTSDALE, Ariz.
Breast pathologist and CAP Cancer Committee chair shares tips for women facing invasive or non-invasive breast cancer diagnosis NORTHFIELD, Ill., April 17, 2015 /PRNewswire-USNewswire/ -- For
SAN DIEGO, April 16, 2015 /PRNewswire/ -- Epic Sciences announced today that its no cell left behind(TM) technology has successfully integrated single cell isolation and downstream
Approval based on improved overall survival, delayed time to radiographic progression and an overall positive risk-benefit profile MARKHAM, ON, April 16, 2015 /CNW/ - Astellas
OXFORD, England, April 16, 2015 /PRNewswire/ -- Immunocore Limited, a world-leading biotechnology company developing novel biological drugs to treat cancer and other diseases,
SEATTLE, April 15, 2015 /PRNewswire/ -- Adaptive Biotechnologies, the company pioneering Next Generation Sequencing (NGS) applications for cancer immunology, and its collaborators will present
GERMANTOWN, Md., April 1, 2015 /PRNewswire/ -- Intrexon Corporation (NYSE: XON), a leader in synthetic biology, today announced
- Stoppage; cessation (of labor).
- A standing still or idling (of mills, factories, etc.).